SCHEMBL5307759

SCHEMBL5307759

COc1cc(CC(=O)Nc2ccc3c(c2)ncn3C(CC(=O)O)c2ccccc2)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.44
ITGB1 P05556 1/20 0.44
ITGA4 P13612 1/20 0.44
BCHE P06276 4/20 0.43
ACHE P22303 4/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ADRA2B P18089 4/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5289524 0.93 ITGB1 (0.44) KDRITGB1ITGA4BCHEACHE
SCHEMBL5303427 0.93 BCHE (0.51) KDRITGB1ITGA4BCHEACHE
SCHEMBL5295744 0.90 BCHE (0.46) ITGB1ITGA4BCHEACHENPC1
SCHEMBL2297605 0.88 SMN1; SMN2 (0.52) KDRNPC1LMNARAB9ASMN1; SMN2
SCHEMBL5305927 0.87 BCHE (0.51) KDRITGB1ITGA4BCHEACHE
SCHEMBL2291248 0.86 USP2 (0.51) NPC1LMNARAB9ASMN1; SMN2KMT2A
SCHEMBL2295562 0.86 LMNA (0.48) NPC1LMNARAB9ASMN1; SMN2ADRA2B
SCHEMBL2291392 0.86 KMT2A (0.51) NPC1LMNARAB9ASMN1; SMN2KMT2A
SCHEMBL5305129 0.85 NPC1 (0.49) KDRITGB1ITGA4NPC1LMNA
SCHEMBL2297135 0.84 KMT2A (0.46) ITGB1ITGA4NPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed